Diabetes Care Portfolio

  • Composition: (Each uncoated bilayered tablet contains)
    • Metformin Hydrochloride (SR) IP – 500 mg
    • Glimepiride IP – 1 mg
    • Voglibose IP – 0.2 mg
    • Excipients – qs.
  • Composition:(Each uncoated bilayered tablet contains)
    • Metformin Hydrochloride (SR) IP – 500 mg
    • Glimepiride IP – 2 mg
    • Voglibose IP – 0.3 mg
    • Excipients – qs.
  • Dosage:

    As directed by physician.

  • Indication:

    Type-2 diabetes.

  • Description:

    A triple drug therapy containing Metformin, Glimepiride and Voglibose. The advanced formulation enables BIOGNIDE GV1/GV2 to disintegrate faster as compared to another marketed brand that makes faster availability of drug at site of absorption. Small tablet size improves patient compliance.